Skip to main content
eLife logoLink to eLife
. 2019 Oct 18;8:e52847. doi: 10.7554/eLife.52847

Correction: HDX-MS reveals structural determinants for RORγ hyperactivation by synthetic agonists

Timothy S Strutzenberg, Ruben D Garcia-Ordonez, Scott J Novick, HaJeung Park, Mi Ra Chang, Christelle Doebellin, Yuanjun He, Rémi Patouret, Theodore M Kamenecka, Patrick R Griffin
PMCID: PMC6799997  PMID: 31625909

Strutzenberg TS, Garcia-Ordonez RD, Novick SJ, Park H, Chang MR, Doebellin C, He Y, Patouret R, Kamenecka TM, Griffin PR. 2019. HDX-MS reveals structural determinants for RORγ hyperactivation by synthetic agonists. eLife 8:e47172. doi: 10.7554/eLife.47172.

Published 7, June 2019

The phenylalanine residues in Figure 1A are labelled with incorrect numbers. The original labels of F377 and F378 were changed to F378 and F388 to match the structure numbering. This residue numbering error does not occur in the text and does not change any of the conclusions of the paper.

The article has been corrected accordingly.


Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

RESOURCES